Physician profile
Caroline Brasher
NPI 1417647868
$1,890.94
in general payments reported to CMS, 2019-2025
16 companies · $857 in 2025
The $857 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,034 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,890.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $343.32 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $280.96 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $261.80 | 2024-2025 | |
| Glaxosmithkline, LLC. | $178.46 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $168.23 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.91 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $99.43 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $91.92 | 2024-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $66.18 | 2024-2025 | |
| Mylan Specialty L.P. | $60.57 | 2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $57.40 | 2024 | Xarelto |
| Dexcom, INC. | $50.30 | 2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $34.12 | 2024-2025 | Gemtesa |
| Otsuka America Pharmaceutical, INC. | $22.02 | 2024 | Rexulti |
| Abbvie INC. | $19.88 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $15.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Brasher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.